Literature DB >> 18751372

Down-regulated expression of RhoA in human conventional renal cell carcinoma.

Yeong-Shiau Pu1, Chuang-Wei Wang, Guang-Yaw Liu, Yi-Zih Kuo, Chao-Yuan Huang, Wang-Yi Kang, Chia-Tung Shun, Chia-Chi Lin, Wen-Jeng Wu, Tzyh-Chyuan Hour.   

Abstract

BACKGROUND: Renal cell carcinoma (RCC) is the most common cancer in adult kidney. Delayed diagnosis may result in progression and metastasis. Markers for early detection of RCC are lacking. The small GTPase RhoA has been implicated in the regulation of cell morphology, motility and transformation, but the role of RhoA in tumorigenesis of RCC remains unclear. In this study, the significance of RhoA expression in human RCC was characterized.
MATERIALS AND METHODS: RhoA mRNA and protein expressions were examined by real-time polymerase chain reaction (PCR) and immunohistochemistry respectively in 46 pairs of tissues.
RESULTS: Real-time PCR revealed that RhoA mRNA expression was significantly lower in cancerous as compared to normal tissues (p = 0.036). RhoA protein expression was significantly higher in normal than in cancerous tissues (p = 0.032). However, RhoA expression did not correlate with age, differentiation grade or TNM stage (all p > 0.05).
CONCLUSION: RhoA down-regulation may be involved in human renal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751372

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

2.  Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation.

Authors:  Chih-Cheng Chang; Kuo-How Huang; Sung-Po Hsu; Yuan-Chii G Lee; Yuh-Mou Sue; Shu-Hui Juan
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.